文献速递肝病

大型住院肝硬化队列中保险状态而非种族和民族与结局相关

Insurance Status But Not Race and Ethnicity Are Associated With Outcomes in a Large Hospitalized Cohort of Patients With Cirrhosis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-05-08

该研究利用北美终末期肝病研究联盟(NACSELD)数据库13家三级中心的2640例住院肝硬化患者数据,分析保险状态、种族和民族与转入重症监护室、慢加急性肝衰竭(ACLF)、住院时间、住院及出院后90天死亡或肝移植、90天内再入院的关系。多变量分析显示,缺乏保险与ACLF相关(P = .02),与住院肝移植(P = .05)及90天肝移植(P = .02)呈负相关;种族或民族与结局无显著关联。

要点

  • 缺乏保险与ACLF相关(P = .02),与住院及90天肝移植呈负相关(P = .05;P = .02)。
  • 种族或民族与所研究的各项结局均无显著关联。
  • 无保险患者中酒精相关或出血相关入院比例最高,肝硬化相关门诊用药使用者比例最低。

核心结论

  • 在NACSELD数据库分析中,无论是否纳入加拿大患者,保险状态而非种族或民族与ACLF及住院或90天肝移植独立相关。

研究设计与样本

  • 研究使用北美终末期肝病研究联盟(NACSELD)数据库,来自13家三级中心,共纳入2640例住院肝硬化患者。
  • 保险状态分为无保险、Medicare、Medicaid、私人保险和加拿大保险;分析其与转入重症监护室、ACLF、住院时间、住院及90天死亡或肝移植、90天内再入院的关系,并构建多变量模型和交互项。

主要发现

  • 2640例患者中,971例有私人保险,770例有Medicare,456例为加拿大保险,265例有Medicaid,178例无保险;540例为非高加索人,220例为西班牙裔。
  • 23%需要转入重症监护室,12%发生NACSELD定义的ACLF,7%死亡,5%接受肝移植。
  • 2288例出院患者中,13%接受肝移植,19%死亡,42%在90天内再入院。
  • 单变量模型中,无保险患者酒精相关或出血相关入院比例最高,肝硬化相关门诊用药使用者比例最低;与其他组相比,加拿大患者利福昔明使用最低但肝性脑病比例更高。
  • 非高加索人中无保险比例更高,无论西班牙裔民族如何;多变量分析中,缺乏保险与ACLF相关(P = .02),与住院肝移植(P = .05)和90天肝移植(P = .02)呈负相关,无论是否纳入加拿大患者或具体保险类型;种族或民族与结局无显著关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Insurance, race, and ethnicity can affect outcomes of patients with cirrhosis, but findings from prospective studies are unclear. We investigated the role of insurance status and race and ethnicity (race/ethnicity) on inpatient and 90-day postdischarge outcomes in a large inpatient cohort of patients with cirrhosis. METHODS: We used data from the North American Consortium for the Study of End-Stage Liver Disease (NACSELD) database, from 13 tertiary care centers. Insurance status (uninsured, Medicare, Medicaid, private, and Canadian), race, and ethnicity, were analyzed independent of clinical covariates for their association with transfer to the intensive care unit, acute on chronic liver failure (ACLF), length of hospital stay, inpatient and 90-day death or liver transplantation, and readmission to the hospital within 90 days. Multi-variable analyses and interaction terms were created for insurance, race/ethnicity, and for each outcome, with or without Canadian patients. RESULTS: We analyzed data from 2640 patients in the NACSELD database (971 with private insurance, 770 with Medicare, 456 Canadians, 265 with Medicaid, 178 uninsured, 540 non-Caucasian and 220 Hispanic); 23% required admittance to the intensive care unit, 12% developed NACSELD-defined ACLF, 7% died, 5% underwent liver transplantation. Of the 2288 patients discharged from hospital, 13% underwent liver transplantation, 19% died, and 42% were readmitted within 90 days. In the univariate model, uninsured patients accounted for the highest percentage of alcohol- or bleeding-related admissions and the lowest proportion of outpatient cirrhosis-related medication users. Canadians had the lowest rifaximin use and but higher proportions had hepatic encephalopathy, compared with other groups. Lack of insurance was higher among non-Caucasians, regardless of Hispanic ethnicity. In multi-variable analysis, lack of insurance was associated with ACLF (P = .02) and inversely associated with inpatient liver transplant (P = .05) and 90-day liver transplant (P = .02), regardless of whether Canadians were included or specific insurance type. Race or ethnicity were not significantly associated with outcomes. CONCLUSIONS: In analyzing the NACSELD database, we found that insurance status, but not race or ethnicity, were independently associated with ACLF and inpatient or 90-day liver transplantation, regardless of inclusion of Canadian patients.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Bajaj JS, O'Leary JG, Tandon P, et al. Insurance Status But Not Race and Ethnicity Are Associated With Outcomes in a Large Hospitalized Cohort of Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2020. PMID: 32389884. doi:10.1016/j.cgh.2020.04.081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。